A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
NuCana plc
Telix Pharmaceuticals (Innovations) Pty Limited
Eli Lilly and Company
Elevation Oncology
Aminex Therapeutics, Inc.
Merck Sharp & Dohme LLC
Fate Therapeutics
Genmab
Instituto do Cancer do Estado de São Paulo
University of Wisconsin, Madison
Lotung Poh-Ai Hospital